These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31987965)

  • 1. Validation of RTOG 0813 Proximal Bronchial Tree Constraints for Pulmonary Toxicity With Stereotactic Body Radiation Therapy for Central Non-small Cell Lung Cancer.
    Manyam BV; Verdecchia K; Videtic GMM; Zhuang T; Woody NM; Wei W; Ouyang Z; Stephans KL
    Int J Radiat Oncol Biol Phys; 2020 May; 107(1):72-78. PubMed ID: 31987965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central Airway Toxicity After High Dose Radiation: A Combined Analysis of Prospective Clinical Trials for Non-Small Cell Lung Cancer.
    Wang W; Matuszak MM; Hu C; Huang KC; Chen E; Arenberg D; Curtis JL; Jolly S; Jin JY; Machtay M; Ten Haken RK; Kong FS
    Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):587-596. PubMed ID: 32470501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
    Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
    J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local control and toxicity in a large cohort of central lung tumors treated with stereotactic body radiation therapy.
    Modh A; Rimner A; Williams E; Foster A; Shah M; Shi W; Zhang Z; Gelblum DY; Rosenzweig KE; Yorke ED; Jackson A; Wu AJ
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1168-76. PubMed ID: 25303891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosimetric Factors and Toxicity in Highly Conformal Thoracic Reirradiation.
    Binkley MS; Hiniker SM; Chaudhuri A; Maxim PG; Diehn M; Loo BW; Shultz DB
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):808-15. PubMed ID: 26831903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatal complications after stereotactic body radiation therapy for central lung tumors abutting the proximal bronchial tree.
    Haseltine JM; Rimner A; Gelblum DY; Modh A; Rosenzweig KE; Jackson A; Yorke ED; Wu AJ
    Pract Radiat Oncol; 2016; 6(2):e27-33. PubMed ID: 26577006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal Tissue Complication Probability Modeling of Pulmonary Toxicity After Stereotactic and Hypofractionated Radiation Therapy for Central Lung Tumors.
    Tekatli H; Duijm M; Oomen-de Hoop E; Verbakel W; Schillemans W; Slotman BJ; Nuyttens JJ; Senan S
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):738-747. PubMed ID: 29413285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First Clinical Report of Proton Beam Therapy for Postoperative Radiotherapy for Non-Small-Cell Lung Cancer.
    Remick JS; Schonewolf C; Gabriel P; Doucette A; Levin WP; Kucharczuk JC; Singhal S; Pechet TTV; Rengan R; Simone CB; Berman AT
    Clin Lung Cancer; 2017 Jul; 18(4):364-371. PubMed ID: 28162946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low rate of thoracic toxicity in palliative paraspinal single-fraction stereotactic body radiation therapy.
    Gomez DR; Hunt MA; Jackson A; O'Meara WP; Bukanova EN; Zelefsky MJ; Yamada Y; Rosenzweig KE
    Radiother Oncol; 2009 Dec; 93(3):414-8. PubMed ID: 19923027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bronchial Stenosis in Central Pulmonary Tumors Treated With Stereotactic Body Radiation Therapy.
    Rijksen BLT; Rossi MMG; Walraven I; Stam B; Knegjens JL; van Diessen JNA; Lalezari F; Sonke JJ; Belderbos JSA
    Pract Radiat Oncol; 2022; 12(5):e382-e392. PubMed ID: 35452867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk-adapted stereotactic ablative radiotherapy for central and ultra-central lung tumours.
    Lenglet A; Campeau MP; Mathieu D; Bahig H; Lambert L; Vu T; Roberge D; Bilodeau L; Filion E
    Radiother Oncol; 2019 May; 134():178-184. PubMed ID: 31005213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric comparison between proton beam therapy and photon radiation therapy for locally advanced esophageal squamous cell carcinoma.
    Hirano Y; Onozawa M; Hojo H; Motegi A; Zenda S; Hotta K; Moriya S; Tachibana H; Nakamura N; Kojima T; Akimoto T
    Radiat Oncol; 2018 Feb; 13(1):23. PubMed ID: 29426342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity after central versus peripheral lung stereotactic body radiation therapy: a propensity score matched-pair analysis.
    Mangona VS; Aneese AM; Marina O; Hymas RV; Ionascu D; Robertson JM; Gallardo LJ; Grills IS
    Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):124-32. PubMed ID: 25442337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatial signature of dose patterns associated with acute radiation-induced lung damage in lung cancer patients treated with stereotactic body radiation therapy.
    Palma G; Monti S; Thor M; Rimner A; Deasy JO; Cella L
    Phys Med Biol; 2019 Aug; 64(15):155006. PubMed ID: 31261141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for symptomatic radiation pneumonitis after stereotactic body radiation therapy (SBRT) in patients with non-small cell lung cancer.
    Liu Y; Wang W; Shiue K; Yao H; Cerra-Franco A; Shapiro RH; Huang KC; Vile D; Langer M; Watson G; Bartlett G; Ai H; Sheski F; Jin JY; Zellars R; Fu P; Lautenschlaeger T; Kong FS
    Radiother Oncol; 2021 Mar; 156():231-238. PubMed ID: 33096168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic ablative radiotherapy for ultra-central lung tumors: prioritize target coverage or organs at risk?
    Murrell DH; Laba JM; Erickson A; Millman B; Palma DA; Louie AV
    Radiat Oncol; 2018 Apr; 13(1):57. PubMed ID: 29606150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic body radiotherapy for central lung tumors.
    Rowe BP; Boffa DJ; Wilson LD; Kim AW; Detterbeck FC; Decker RH
    J Thorac Oncol; 2012 Sep; 7(9):1394-9. PubMed ID: 22843088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ablative radiotherapy for ultracentral lung cancers: Dosimetric, geometric, and volumetric predictors of outcomes and toxicity.
    Breen WG; Jeans EB; Gergelis KR; Garces YI; Park SS; Merrell KW; Peikert TD; Mansfield AS; Wigle DA; Harmsen WS; Ellerbusch DC; Olivier KR; John Lucido J; Owen D
    Radiother Oncol; 2021 May; 158():246-252. PubMed ID: 33711411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary dose-volume predictors of radiation pneumonitis following stereotactic body radiation therapy.
    Harder EM; Park HS; Chen ZJ; Decker RH
    Pract Radiat Oncol; 2016; 6(6):e353-e359. PubMed ID: 27156424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes and toxicity of stereotactic body radiation therapy for advanced stage ultra-central non-small cell lung cancer.
    Cong Y; Sun B; Wang J; Meng X; Xuan L; Zhang J; Liu J; Shen G; Wu S
    Thorac Cancer; 2019 Jul; 10(7):1567-1575. PubMed ID: 31187604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.